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The normal crystalline lens is isolated by a basement membrane, the lens capsule. A 
single layer of cuboidal lens epithelial cells (LEC) lines the anterior lens capsule and 
continuously secretes the lens capsule. The majority of the lens is composed of fibers that are 
arranged in a central nucleus and a peripheral cortex. Cataract is defined as any opacity of the 
lens and is the most common cause of visual impairment in both humans and dogs (Andersson et 
al. 1994; Buyukmihci et al. 1987; Cheng et al. 2001; Schaumberg et al. 1998). Cataracts develop 
secondary to endocrine disorders (Basher et al. 1995), inherited or congenital causes (Davidson 
et al. 2007; Priester et al. 1972), toxins (Davidson et al. 2007), electrolyte imbalances (Davidson 
et al. 2007), electric shock (Davidson et al. 2007), trauma (Davidson et al. 2007), drugs 
(Heywood 1971), radiation (Ching et al. 1990; Lett et al. 1989; Roberts et al. 1987), nutritional 
deficits (Ranz et al 2002), retinal atrophy Barnett 1970), intraocular inflammation (Albert et al. 
1976; Bistner 1973; Buyukmihci et al. 1987), and from age-related degeneration (Davidson et al. 
2007). When the lens becomes cataractous, the LECs may migrate and proliferate aberrantly on 
the posterior lens capsule (Apple et al. 1992). Other changes that occur during cataractogenesis 
include the formation of bladder or Wedl cells which are swollen LECs, as well as 
myofibroblastic differentiation of the LECs to form capsular plaques. Advanced cortical 
cataracts have a decreased amount of LEC resulting from cell degeneration. Fluid from lytic lens 
proteins may accumulate in small clefts formed between degenerative fibers and is associated 
with vacuolization of lens fibers and pyknotic nuclei. 
Cataract surgery is currently the only accepted treatment for cataracts and related vision 
loss and is the current standard of care. Extracapsular cataract extraction by phacoemulsification 
with subsequent intraocular lens (IOL) implantation is the most frequently performed ophthalmic 
surgical procedure, with a success rate of greater than 95% (Beebe 2003; Davison et al. 1999). 
During cataract surgery, part of the anterior lens capsule is removed by a capsulectomy. The lens 
fibers are removed via phacoemulsification, and the lens capsule may be polished to decrease the 
number of residual LECs prior to IOL implantation. Viscoelastic is used to inflate the anterior 
chamber as well as to inflate the lens capsule prior to IOL implantation. Quality of life following 
cataract surgery is markedly improved, as reported by humans who have undergone cataract 
surgery. There is also the perception, by owners, of an improved quality of life in canine 
companions that have had cataract surgery. 
Complications of cataract surgery include retinal detachment, glaucoma, incisional 
dehiscence, intraocular infection, IOL decentration, and the most common postoperative 
complication, posterior capsule opacification (PCO) (Noble 2002). Posterior capsule 
opacification refers to opacities of the posterior lens capsule following cataract surgery that can 
lead to diminished vision either directly by the LECs or indirectly by posterior capsule wrinkles 
and striae or by IOL decentration that can induce visual aberrations (Apple et al. 1972). 
Following cataract surgery, LEC may migrate across the inner surface of the lens capsule, across 
the IOL optic, or they may migrate around the capsulotomy edge onto the outer surface of the 
capsule. When these cells migrate to the posterior portion of the lens capsule, they may create 
PCO. The LECs may also show increased metabolic activity, become vacuolated, and take on the 
appearance of clear pearl-shaped cells or vacuoles, termed Elschnig’s pearls. 
Phacoemulsification, IOL placement, and residual or new growth of lens cortical material 
can all lead to blood-aqueous barrier breakdown and intraocular inflammation (Nishi and Nishi 
2002). It is well established that intraocular inflammation and surgical disruption of the anterior 
lens capsule initiate cell signaling where the primary response of any remaining anterior and 
equatorial LEC is to undergo epithelial-mesenchymal transition (EMT) (Awasthi et al. 2008; 
Chandler et al. 2007). This results in the posterior migration and proliferation of the LEC that is 
associated with PCO formation with subsequent vision impairment. EMT refers to a change in 
phenotype from a cuboidal epithelial cell to fibroblastic morphology accompanied by aberrant 
basement membrane synthesis (Awasthi et al. 2008; Chandler et al. 2007). However, this process 
is not completely understood for any species. The pathway to PCO formation is very complex 
and, therefore, offers numerous sites for possible inhibition chemically, pharmacologically, or 
mechanically.  
The impact of PCO on vision includes decreased visual acuity, diplopia, glare, and 
decreased contrast sensitivity (Buehl et al. 2005; Buehl et al. 2005; Cheng et al. 2001; Claesson 
et al. 1994; Jose et al. 2005; Sunderraj et al. 1992). PCO can also cause a decrease in visual 
acuity by opacification of the visual axis. Opaque PCO, also called capsular fibrosis or scarring, 
that occurs in the visual axis may impair vision as much as the original cataractous lens (Buelg et 
al. 2005). PCO is seen in up to 50% of adult humans up to five years postoperatively (Apple et 
al. 1992; Mootha et al. 2004; Schaumberg et al. 1998), in up to 43% of children one year post-
operatively (Metge et al 1989), and in up to 100% of children (Apple et al. 1992) and dogs 
within one year after cataract surgery (Bras et al. 2006). 
Hyaluronan, also known as hyaluronic acid or hyaluronate, is a uniformly repetitive, 
linear glycosaminoglycan composed of disaccharides of glucuronic acid and N-
acetylglucosamine (Toole 2001). Although hyaluronic acid (HA) is distributed ubiquitously in 
vertebrate tissues, both in the embryo and in the adult, its organization with respect to cells is 
variable. In adult tissues such as the vitreous humor, synovial fluid and dermis, it clearly plays an 
extracellular, structural role based on its unique hydrodynamic properties. However, during 
dynamic cellular events such as inflammation, wound repair, tissue development and cancer, HA 
also interacts with cells and influences their behavior in a variety of ways (Lee and Spicer 2008; 
Toole 2004; Toole 2001; Turley et al. 2002; Vigetti et al. 2008). 
There are at least three fundamentally different ways in which HA can influence normal 
and abnormal cell behavior. First, due to its biophysical properties, unbound HA has a profound 
effect on the biomechanical properties of extracellular and pericellular matrices in which cells 
reside (Toole 2001). Second, HA forms a multivalent template for specific interactions with 
other pericellular macromolecules, thus contributing to the assembly, structural integrity and 
physiological properties of matrices (Toole 2001). In these two ways, HA makes the pericellular 
matrix more conducive to cell shape changes required for cell division, movement and 
morphogenesis, and thus contributes to cell behavior in what has been called a ‘permissive’ 
fashion. A third function of HA is to interact with cell surface receptors that transduce 
intracellular signals and influence cellular form and behavior directly (Bourguinon et al. 2001; 
Day and Prestwich 2002; Herrlich et al. 2000; Noble 2002; Toole 2004). Thus HA also has an 
‘instructive’ influence on cell behavior. 
The biological functions of HA are essentially mediated by cell surface HA receptors, 
including CD44 and the receptor for HA mediated motility (RHAMM). The CD44 ectodomain is 
responsible for the binding of HA, and the cytoplasmic domain regulates specific signaling and 
interacts with cytoskeletal proteins (Bourguinon et al. 2001). Using immunohistochemistry, 
Saika et al (Saika et al. 1998) determined that CD44 is ubiquitously expressed in human LEC; 
CD44 expression is unknown in the canine lens. RHAMM is an 85-kDa protein expressed in 
most tissues, distributed in multiple compartments including cell surface, cytoskeleton, 
mitochondria and the cell nucleus (Turley et al. 2002). RHAMM binds HA and also acts as a 
microtubule-associated protein interacting with the actin cytoskeleton (Assmann et al. 1999; 
Turley et al. 2002). To date, expression of RHAMM has not been examined in the lens. The 
relative contribution of the two types of HA receptors and the intracellular signaling pathways 
involved in HA-mediated effects in LEC remain unknown. It is well established in other tissue 
types that HA will bind with cell receptors CD44 and RHAMM and increase cellular migration 
and proliferation (Bourguinon et al. 2001; Kayastha et al. 1999; Panagopoulos et al. 2008). In 
patients with cancer, HA concentrations are usually higher in malignant tumors than in 
corresponding benign or normal tissues, and in some tumor types the level of HA is predictive of 
malignancy (Kayastha et al. 1999). In patients with breast and ovarian carcinomas as well as B-
cell lymphoma, high levels of HA, CD44 and RHAMM expression in the stroma are consistent 
with low survival rates (Kayastha et al. 1999; Nagel et al. 2010).  
Viscoelastics are used to inflate the anterior chamber and lens capsule intraoperatively 
during cataract surgery and HA is a common component of these viscoelastics. There are various 
viscoelastics used in intraocular surgery including 1.2% HA, 2.0% HA, chondroitin sulfate or 
hydroxypropylmethylcellulose (HPMC). Viscoelastics are generally removed at the conclusion 
of cataract surgery; however, removal of these viscoelastics is never complete. HA has been 
shown to induce EMT in other cell types such as meningiomas and thus, the introduction of 
exogenous HA in the form of viscoelastics during cataract surgery may promote LEC migration 
and proliferation and subsequently, PCO formation. This study was performed to evaluate if 
canine LECs are capable of responding to hyaluronic signaling of CD44 and RHAMM as well as 
to evaluate if lens epithelial cell migration and proliferation will be increased using viscoelastics 
with higher hyaluronic acid content. 
 
Materials and Methods 
Samples:  
Normal eyes were obtained by enucleation from dogs in good general health that were humanely 
euthanized at a local animal shelter for population control purposes.  All dogs used in this study 
were estimated to be between one and eight years of age, based on dentition and thickness of the 
anterior lens capsule.  Globes were collected within one hour of death and placed in dilute 
betadine solution until dissection. Normal lenses and lens capsules were obtained after dissection 
and placed in 10% neutral-buffered formalin.  
Cataractous lens capsules were obtained from dogs undergoing elective cataract surgery 
at The Ohio State University College of Veterinary Medicine. These capsules were harvested 
from immature, mature, and hypermature cataracts. The most common etiologies for the 
cataracts were diabetes mellitus and inherited. These capsules were then used for 
immunohistochemistry, western blots, and qualitative real-time polymerase chain reaction. 
 
Positive Controls for CD44 and RHAMM 
A total of five paraffin-embedded neoplasms from dogs were utilized in this study for 
CD44. One canine squamous cell carcinoma, one canine complex mammary adenoma, one 
canine mammary carcinoma, one canine mixed mammary tumor, and one canine cutaneous 
hemangiosarcoma. To evaluate RHAMM, seven paraffin-embedded neoplasms from dogs were 
utilized in this study for RHAMM. Three normal testicles, a sertoli cell tumor, and three 
squamous cell carcinomas were evaluated. Samples were obtained from the Department of 
Veterinary Biosciences, at The Ohio State University and were diagnosed by various board-
certified veterinary pathologists.  
 Immunohistochemistry of CD44 and RHAMM 
The standard avidin-biotin-peroxidase complex (ABC) technique was used with 
diaminobenzidine (DAKO, Carpinteria, CA) as the chromagen and Mayers hematoxylin (Signet 
Laboratories, Dedham, MA) as the counterstain. Paraffin-embedded samples were sectioned 
(5um) and placed on Probe-On Plus slides (Fisher Scientific, Pittsburgh, PA). Five cataractous 
lens capsules and six normal lens capsules were evaluatated for the presence of CD44. Sixteen 
cataractous lens capsules and eight normal lens capsules were evaluated for the presence of 
RHAMM. Slides were decerated in xylenes, rehydrated through a graded series of alcohols, and 
rinsed in phosphate-buffered saline (PBS). Slides were incubated with peroxidase block (DAKO) 
for ten minutes at room temperature, washed in PBS, and then incubated with a protein block 
(DAKO) for twenty minutes at room temperature. Sections were incubated for one hour at 37° C 
in a humidified chamber with one of the following primary antibodies diluted in antibody diluent 
(DAKO): CD44 (Santa Cruz Biotechnology, INC., Santa Cruz, CA) diluted to 1:400 or 
RHAMM (Santa Cruz Biotechnology, INC., Santa Cruz, CA) diluted 1:50. Sections were then 
rinsed in PBS and incubated with anti-rat secondary antibody (Biogenex, San Ramon, CA) 
solution for thirty minutes at room temperature. Slides were washed a final time in IX PBS 
before incubation with the chromagen and counterstain. Slides were washed again with tap water 
until clear and then dehydrated. Slides were gradually passed through 70%, 85%, 100% ethanol 
until a final two-minute incubation in xylenes. Slides were then coversliped with Permount 
mounting solution. 
Following staining, the slides were evaluated by the authors (DJH, HLC). The slides were 
assessed for staining intensity and location. 
 qRT-PCR of Normal and Cataractous Lens for CD44 and RHAMM 
RNA was extracted from normal and cataractous anterior lens capsule samples according 
to the suggested protocol using Absolutely RNA Microprep Kit (Stratagene, La Jolla, CA).  The 
ImPromII Reverse Transcriptase kit (Promega, Madison, WI) was used to synthesize the first 
strand of cDNA.  Quantitative reverse transcription polymerase chain reaction (RT-PCR) was 
performed using the Mx3000p Multiplex Quantitation System (Stratagene) as follows: 95° C for 
fifteen minutes, then forty cycles at 94° C for thirty seconds, 60° C for thirty seconds, and 70° C 
for thirty seconds, using the QuantiTect SYBR Green PCR kit (Stratagene).  Primers to amplify 
sequences of CD44 and RHAMM were designed based on previously published sequence data. 
Primers to amplify the sequence for glyceraldehydes-3-phosphate dehydrogenase (GAPDH; 
housekeeping control) were based on previously published sequence data. Primers employed 
were:  
 CD44 Forward: 5′-CCA AGA CAG TTC CAG GGT GT-3′ 
 CD44 Reverse: 5′-TCG ACT ATT GAC AGC GAT GC-3′ 
RHAMM Forward: 5′-TCT GCA CTT TTC TCA GCC CTG GT-3′ 
 RHAMM Reverse: 5′-TGC  TGC TCA CAG TCA AGC CAC T-3′ 
GAPDH forward: 5′-GCC GTG GAA TTT GCC GT-3' 
GAPDH reverse: 5′-GCC ATA AAT GAC CCC TTC AT-3' 
 All samples were run in duplicate three separate times.  The threshold cycle value was 
calculated for each sample by the instrument software. The relative amount of CD44, RHAMM, 
and HPRT mRNA was calculated using the LinRegPCR software (v. 11.x; JM Ruijter, S van der 
Velden, A Ilgun, Amsterdam, the Netherlands).  The results were expressed as the ration of the 
target gene (CD44 or RHAMM) to the HPRT housekeeping gene.  
 
Primary canine lens epithelial cell cultures 
Anterior lens capsules with adherent LEC were incubated in trypsin (0.25% trypsin and 
1X EDTA, Gibco, Carlsbad, CA) for five minutes at 37° C.  After incubation, the solution and 
lens capsule were centrifuged for two minutes at 0.3 x g.  Fluid was decanted and supplemented 
DMEM (10% fetal bovine serum and 1% antibiotic/antimycotic [Gibco]) was then added. The 
solution, including the lens capsule, was transferred to a laminin-coated culture flask (Beckton-
Dickinson, Franklin Lakes, NJ) an incubated in a humidified incubator at 37° C and 5% CO2.  
LEC were grown until 90% confluence prior to re-plating.  
 
Scratch model to induce epithelial-mesenchymal transition 
Lens epithelial cells in each well were allowed to grow to 90% confluence in 
unsupplemented DMEM in a twelve-well laminin coated culture dish. A vertical one mm scratch 
was then made on the cellular surface. Cells were then treated with unsupplemented DMEM, 
0.012 mg/mL of HA, 0.02 mg/mL of HA, and 1 mg/mL of HA (n=6) and allowed to recover for 
sixteen hours. The HA (Sigma) was prepared in unsupplemented DMEM. Digital images were 
taken immediately after the initial scratch was made and sixteen hours after healing. ImageJ 
(National Institutes of Health) was then used to quantify the cellular migration and proliferation.  
 
Mock Cataract Surgery 
A stab incision was made into the anterior chamber avoiding the lens. The cornea was 
completely removed with Steven’s tenotomy scissors and the iris was removed using Vannas 
scissors. An anterior capsulorhexis was performed using Vannas scissors exposing the lens 
nucleus and cortex. The lens nucleus and cortex were removed using a lens loop. All capsules 
were irrigated with PBS and aspirated prior to incubation with viscoelastic agent or the control to 
remove residual lens fibers and LECs. However, not all LECs were removed prior to capsule 
dissection.  For the control group (n=6 capsules), the lens capsule was irrigated a second time 
using PBS. The remaining eyes were then divided into three treatment groups (n=6 capsules per 
group) and treated with either 2% hyaluronic acid viscoelastic (Acri.Tec, Hennigsdorf, 
Germany), 1.2% hyaluronic viscoelastic (Acri.Tec), or HPMC viscoelastic (contains no 
hyaluronic acid) (Acri.Tec,). The various viscoelastic agents were left in the lens capsule for five 
minutes, then the viscoelastic was aspirated and then irrigated with PBS to ensure removal of 
treatment. Capsules were then removed from their zonular and vitreal attachments with Vannas 
scissors and placed in culture dishes with five milliliters of unsupplemented DMEM. The plates 
were then placed in a 37° C / 5% carbon dioxide incubator. Phase contrast microscopy pictures 
were taken of the capsules immediately after adding cell culture medium, and every twenty-four 
hours after the treatment to monitor LEC migration onto the posterior capsule. 
 
Results 
Immunohistochemistry of CD44 and RHAMM 
Antibody specificity was confirmed using canine corneal epithelial cell lysate and canine 
MCDK cell lysate in western blot analysis.  Of six normal lens capsules, three normal lens 
capsules exhibited positive expression (Figure 1) and three normal lens capsules were negative 
for expression of CD44. All five cataractous lens capsules that were evaluated were positive for 
CD44 expression (Figure 2). Eight normal lens capsules were evaluated for RHAMM expression 
and of these, seven demonstrated immunoreactivity (Figure 3) and one was negative. Sixteen 
cataractous lens capsules were evaluated for RHAMM expression and of these samples, fifteen 
were positive for RHAMM expression (Figure 4) and one sample was negative. All lens 
epithelial cells that were positive for CD44 and RHAMM staining exhibited cytoplasmic 
staining, which was similar to what was seen in our positive controls. 
 
qRT-PCR of Normal and Cataractous Lens for CD44 and RHAMM 
Both cataractous and normal lens capsules were evaluated for mRNA expression of CD44 or 
RHAMM relative to GAPDH. Normal lens capsules showed an mRNA expression of 6.1 for 
CD44 and 5.9 for RHAMM as compared to GAPDH. In contrast, cataractous lens capsules 
showed an mRNA expression of 10.0 for CD44 and 7.0 for RHAMM as compared to GAPDH. 
 
Scratch model to induce epithelial-mesenchymal transition 
Lens epithelial cell cultures were evaluated immediately after creation of a scratch 
(referred to as time zero) and sixteen hours after creating the scratch. A one-way Analysis of 
Variance with a Bonferroni Multiple Comparison Test was performed to evaluate differences in 
the area of the scratch devoid of cells between the four treatment groups (DMEM only, 0.012 
mg/mL HA, 0.02 mg/mL HA, 1.0 mg/mL HA). All time zero cultures compared with time 
sixteen within the same treatment group showed a statistically significant difference between the 
area of the scratch devoid of cells. There was a significant difference (p<0.001) between the area 
of the scratch at time sixteen hours of the group receiving DMEM compared with the area of the 
scratch at time sixteen hours of cells treated with 1.0mg/mL of HA (Figure 5).  
 
Mock Cataract Surgery 
Capsules were evaluated by phase contrast microscopy to evaluate the extent of migration 
and proliferation of LECs from the anterior capsule to the posterior lens capsule. Our time period 
to allow contact of the LECs with HA was five minutes. Many times, surgeons are able to 
remove the viscoelastic with less than five minutes of LEC contact time; however, we felt this 
was a reasonable amount of time that would correlate surgically in the clinical setting.  Cells 
from the control group (PBS only) were consistently found only on the anterior lens capsule 
(Figure 6). Cells from the HPMC group, the viscoelastic material that contains no HA, migrated 
to the same extent as the control group, as LEC consistently remained on the anterior lens 
capsule after three days (Figure 7). Cells from the 1.2% HA treated group showed minimal 
migration onto the posterior lens capsule, however did not cross the midline, or visual axis, of 
the posterior lens capsule. Cells from the 2.0% HA treated group showed extensive migration 
onto the posterior lens capsule and frequently migrated beyond the posterior capsule midpoint 
into the region of the visual axis and achieved 90% confluence on the posterior capsule. 
 
Discussion 
Posterior capsule opacification affects 50% of adult human (Apple et al. 1992; Mootha et 
al. 2004; Schaumberg et al. 1998) and up to 43% of children (Metge et al. 1989) and one 100% 
of dogs (Bras et al. 2006) after cataract surgery within one year. Due to this high incidence of 
postoperative PCO formation, surgical and medical techniques are being investigated to address 
this vision-impairing complication. Hyaluronic acid is a common component of surgical 
viscoelastics, however to our knowledge, this compound has not been evaluated as to its effects 
on the LECs and whether it has the ability to influence posterior proliferation and migration. In 
this study we evaluated HA cell surface receptors CD44 and RHAMM and confirmed their 
presence in canine LECs. We also evaluated the ability of canine LECs to respond to HA, 
utilizing a scratch test model as well as a mock cataract surgery on canine cadaver eyes. 
 The biological functions of HA are essentially mediated by cell surface HA receptors, 
CD44 and RHAMM. CD44 comprises a large family of transmembrane glycoproteins that 
exhibit extensive molecular heterogeneity. The CD44 ectodomain is responsible for the binding 
of HA, and the cytoplasmic domain regulates specific signaling and interacts with cytoskeletal 
proteins. CD44 expression was previously unknown in the canine lens. RHAMM is an 85-kDa 
protein expressed in most tissues, distributed in multiple compartments including cell surface, 
cytoskeleton, mitochondria and cell nucleus (Turley et al. 2002). RHAMM binds to HA and also 
acts as a microtubule-associated protein interacting with the actin cytoskeleton (Assmann et al. 
1999; Schaumberg et al. 1998). Previous to this study, RHAMM expression has not been 
evaluated in the lens of any species. In this study, immunohistochemistry was performed and 
identified the presence of CD44 and RHAMM in both normal and cataractous LECs. Saika et al. 
previously determined that CD44 is present in human LECs (Saika). Therefore, canine LECs 
have the ability to respond to HA signaling. It has been well established in other tissue types that 
HA increases cellular migration and proliferation through CD44 and RHAMM signaling 
pathways (Bourguinon et al. 2008; Panagopoulos et al. 2008; Toole 2004). In patients with 
various forms of cancer, HA concentration is usually higher in malignant tumors than in 
corresponding benign or normal tissues and in some tumor types the level of HA is predictive of 
malignancy (Kayastha et al. 1999; Nagel et al. 2010). Since migration and proliferation can be 
induced, and since CD44 and RHAMM are expressed in LEC, these cells may respond by 
increasing migration and proliferation. 
 qRT-PCR for CD44 and RHAMM expression in normal and cataractous LEC were 
evaluated in this study. This technique demonstrated that CD44 and RHAMM mRNA expression 
is present in both normal and cataractous LEC as compared to GAPDH. Cataractous lens 
capsules showed a four-fold increase in CD44 mRNA expression and a negligible increase in 
RHAMM mRNA expression  as compared to normal lens capsules.  
 Following sixteen hours, the scratch test model showed that there was a significant 
difference in the area devoid of cells between the control group versus the LEC treated with 1.0 
mg/mL of HA. This study showed that there was not a significant difference between any of the 
groups except for the time sixteen hours for the control group versus time sixteen hours for the 
1.0 mg/mL HA.  However, there was a trend of increasing rate of scratch wound closure in each 
group as HA content increased. Therefore, in vitro, LECs respond to HA  by increasing the rate 
of migration and proliferation, and the response appears to be concentration dependent.  
 The mock cataract surgery model showed that, subjectively, in lens capsules treated with 
viscoelastics with higher HA content greater migration of LECs onto the posterior lens capsule 
occurred. The results of this study suggest that higher concentrations of HA in viscoelastic 
materials used in clinical cataract surgery could potentially increase PCO in vivo. 
 This study demonstrates that CD44 and RHAMM are present in canine LECs and 
therefore, LECs have the ability to respond to HA signaling. Further in vivo studies are 
warranted to evaluate if viscoelastics both with and without HA increase the extent of PCO. 
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